Nidhogg Resources Holding secures utilization of TO6 warrants for SEK 5 million, cancels negotiations regarding the acquisition of approximately 85.18 percent of the shares in Holmasjön
Nidhogg Resources Holding AB (publ) ("the Company" or "Nidhogg") has secured an agreement regarding the utilization of TO6 series warrants ("TO6") with exercise period betweenRead…
Nidhogg Resources Holding AB and GreenIron Sign a Memorandum of Understanding for Fossil-Free Metal Processing
Nidhogg Resources Holding AB ("Nidhogg"), a Swedish mining company and GreenIron (“GreenIron”), a company providing fossil-free metal processing technology, are pleased to announce the signingRead…
Nidhogg Resources Plans a Geophysical Survey to Investigate the Extent of Anomalies Between Vintjärn and Kölen
Nidhogg Resources Holding AB (publ) ("The Company") has today submitted work plans to landowners and the Swedish Mining Inspectorate (”Bergsstaten”) to conduct a geophysical surveyRead…
Nidhogg Resources Holding AB (publ) submits consultation material as part of the plan for trial mining at the Vintjärn mine and increases ownership by 10% in Big Rock Mineral AB
Nidhogg Resources Holding AB (publ) (“The Company”) has today submitted consultation material to the County Administrative Board in Dalarna as part of an Environmental ImpactRead…
Nidhogg Resources Holding secures the utilization of TO6 warrants at 100% with a conditional agreement; entered into a Letter of Intent regarding the acquisition of 85.18% of the shares in Holmasjön
Nidhogg Resources Holding AB (publ) (“The Company” or “Nidhogg”) has agreed to secure the utilization of series TO6 warrants (“TO6”) with an exercise period fromRead…
Nidhogg Resources Holding AB (publ) submits ore from Vintjärn to analyze a fossil-free beneficiation technology for metal extraction.
Nidhogg Resources Holding AB (publ) (the “Company”), has today submitted two ore samples for beneficiation analysis from the Kölen Vintjärn area. One from the VintjärnRead…
Eurocine Vaccines contracts Artemis Bioservices as CRO
Eurocine Vaccines AB (publ) ("Eurocine Vaccines" or "the Company") announces today that the Company has contracted Artemis Bioservices B.V. (”Artemis Bioservices”) as a CRO (Contract…
Correction – Eurocine Vaccines discloses interim report for July – September 2023
Correction to previous press release since the interim report was not attached earlier. Eurocine Vaccines AB (publ) (”Eurocine Vaccines) hereby discloses the interim report for…
Eurocine Vaccines discloses interim report for Juli – September 2023
Eurocine Vaccines AB (publ) (”Eurocine Vaccines) hereby discloses the interim report for July to September 2023. Below is a summary of the report. The full…
Eurocine Vaccines discloses year-end report for the fiscal year 2022/2023
Eurocine Vaccines AB (publ) (”Eurocine Vaccines) hereby discloses the year-end report for the fiscal year 2022/2023. Below is a summary of the report. The full…